Listed

Vor Biopharma Inc.

VORNasdaqCIK 1817229HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$58.4m, Q3 FY2026
Net income−$86.7m, Q3 FY2026
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Research and development$m20.9Research and development, Q4 FY2023, three months to 2023-12-31$20.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-20, accession 0000950170-25-042623. Derived: 12-month figure less the 9-month figure.Report this figure24.3Research and development, Q1 FY2024, three months to 2024-03-31$24.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0000950170-25-071349.Report this figure21.8Research and development, Q2 FY2024, three months to 2024-06-30$21.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107276.Report this figure21.8Research and development, Q3 FY2024, three months to 2024-09-30$21.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figure25.3Research and development, Q4 FY2024, three months to 2024-12-31$25.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001193125-26-130451. Derived: 12-month figure less the 9-month figure.Report this figure26.7Research and development, Q1 FY2025, three months to 2025-03-31$26.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure261Research and development, Q2 FY2025, three months to 2025-06-30$261.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure14.1Research and development, Q3 FY2025, three months to 2025-09-30$14.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure19.2Research and development, Q4 FY2025, three months to 2025-12-31$19.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001193125-26-130451. Derived: 12-month figure less the 9-month figure.Report this figure17.6Research and development, Q1 FY2026, three months to 2026-03-31$17.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure25.9Research and development, Q2 FY2026, three months to 2026-06-30$25.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure34.5Research and development, Q3 FY2026, three months to 2026-09-30$34.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure
Operating income$m(28.1)Operating income, Q4 FY2023, three months to 2023-12-31−$28.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-20, accession 0000950170-25-042623. Derived: 12-month figure less the 9-month figure.Report this figure(32.3)Operating income, Q1 FY2024, three months to 2024-03-31−$32.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0000950170-25-071349.Report this figure(29.0)Operating income, Q2 FY2024, three months to 2024-06-30−$29.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107276.Report this figure(28.5)Operating income, Q3 FY2024, three months to 2024-09-30−$28.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figure(31.3)Operating income, Q4 FY2024, three months to 2024-12-31−$31.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-130451. Derived: 12-month figure less the 9-month figure.Report this figure(33.3)Operating income, Q1 FY2025, three months to 2025-03-31−$33.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure(274)Operating income, Q2 FY2025, three months to 2025-06-30−$274.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure(28.1)Operating income, Q3 FY2025, three months to 2025-09-30−$28.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure(36.0)Operating income, Q4 FY2025, three months to 2025-12-31−$36.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-130451. Derived: 12-month figure less the 9-month figure.Report this figure(35.2)Operating income, Q1 FY2026, three months to 2026-03-31−$35.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure(47.9)Operating income, Q2 FY2026, three months to 2026-06-30−$47.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure(58.4)Operating income, Q3 FY2026, three months to 2026-09-30−$58.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure
Net income$m(26.3)Net income, Q4 FY2023, three months to 2023-12-31−$26.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-20, accession 0000950170-25-042623. Derived: 12-month figure less the 9-month figure.Report this figure(30.8)Net income, Q1 FY2024, three months to 2024-03-31−$30.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figure(27.8)Net income, Q2 FY2024, three months to 2024-06-30−$27.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figure(27.6)Net income, Q3 FY2024, three months to 2024-09-30−$27.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figure(30.7)Net income, Q4 FY2024, three months to 2024-12-31−$30.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-130451. Derived: 12-month figure less the 9-month figure.Report this figure(32.5)Net income, Q1 FY2025, three months to 2025-03-31−$32.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure(1,574)Net income, Q2 FY2025, three months to 2025-06-30−$1.57bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure(813)Net income, Q3 FY2025, three months to 2025-09-30−$812.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure1,723Net income, Q4 FY2025, three months to 2025-12-31$1.72bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-130451. Derived: 12-month figure less the 9-month figure.Report this figure(220)Net income, Q1 FY2026, three months to 2026-03-31−$219.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure(62.8)Net income, Q2 FY2026, three months to 2026-06-30−$62.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure(86.7)Net income, Q3 FY2026, three months to 2026-09-30−$86.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure
Diluted EPS$ per sharenot reported(0.45)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0000950170-25-071349.Report this figure(0.41)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0000950170-25-107276.Report this figure(8.05)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$8.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figurenot reported(5.21)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$5.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure(251.24)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$251.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure(121.63)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$121.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figurenot reported(5.11)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$5.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure(1.16)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure(1.45)Diluted EPS, Q3 FY2026, three months to 2026-09-30−$1.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure
Basic EPS$ per sharenot reported(0.45)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0000950170-25-071349.Report this figure(0.41)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0000950170-25-107276.Report this figure(8.05)Basic EPS, Q3 FY2024, three months to 2024-09-30−$8.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figurenot reported(5.21)Basic EPS, Q1 FY2025, three months to 2025-03-31−$5.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure(251.24)Basic EPS, Q2 FY2025, three months to 2025-06-30−$251.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure(121.63)Basic EPS, Q3 FY2025, three months to 2025-09-30−$121.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figurenot reported(5.11)Basic EPS, Q1 FY2026, three months to 2026-03-31−$5.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure(1.16)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure(1.45)Basic EPS, Q3 FY2026, three months to 2026-09-30−$1.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure

Balance sheet

Cash and equivalents$79.0m, Q3 FY2026
Shareholders' equity−$137.2m, Q3 FY2026
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Cash and equivalents$m31.4Cash and equivalents, FY2023, at 2023-12-31$31.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-20, accession 0000950170-25-042623.Report this figure45.0Cash and equivalents, Q1 FY2024, at 2024-03-31$45.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0000950170-25-071349.Report this figure76.1Cash and equivalents, Q2 FY2024, at 2024-06-30$76.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0000950170-25-107276.Report this figure52.8Cash and equivalents, Q3 FY2024, at 2024-09-30$52.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figure81.9Cash and equivalents, FY2024, at 2024-12-31$81.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001193125-26-130451.Report this figure50.0Cash and equivalents, Q1 FY2025, at 2025-03-31$50.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure191Cash and equivalents, Q2 FY2025, at 2025-06-30$190.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure160Cash and equivalents, Q3 FY2025, at 2025-09-30$160.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure396Cash and equivalents, FY2025, at 2025-12-31$396.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure170Cash and equivalents, Q1 FY2026, at 2026-03-31$169.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure108Cash and equivalents, Q2 FY2026, at 2026-06-30$107.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure79.0Cash and equivalents, Q3 FY2026, at 2026-09-30$79.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure
Current assets$m141Current assets, FY2023, at 2023-12-31$140.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-20, accession 0000950170-25-042623.Report this figure112Current assets, Q1 FY2024, at 2024-03-31$111.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056846.Report this figure90.3Current assets, Q2 FY2024, at 2024-06-30$90.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093858.Report this figure67.3Current assets, Q3 FY2024, at 2024-09-30$67.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123245.Report this figure96.5Current assets, FY2024, at 2024-12-31$96.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001193125-26-130451.Report this figure64.8Current assets, Q1 FY2025, at 2025-03-31$64.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071349.Report this figure205Current assets, Q2 FY2025, at 2025-06-30$204.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107276.Report this figure172Current assets, Q3 FY2025, at 2025-09-30$172.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figure458Current assets, FY2025, at 2025-12-31$458.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure501Current assets, Q1 FY2026, at 2026-03-31$500.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure475Current assets, Q2 FY2026, at 2026-06-30$475.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure491Current assets, Q3 FY2026, at 2026-09-30$490.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure
Total assets$m198Total assets, FY2023, at 2023-12-31$198.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-20, accession 0000950170-25-042623.Report this figure167Total assets, Q1 FY2024, at 2024-03-31$167.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056846.Report this figure142Total assets, Q2 FY2024, at 2024-06-30$141.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093858.Report this figure116Total assets, Q3 FY2024, at 2024-09-30$116.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123245.Report this figure143Total assets, FY2024, at 2024-12-31$142.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001193125-26-130451.Report this figure109Total assets, Q1 FY2025, at 2025-03-31$109.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0000950170-25-071349.Report this figure205Total assets, Q2 FY2025, at 2025-06-30$205.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-107276.Report this figure176Total assets, Q3 FY2025, at 2025-09-30$176.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figure464Total assets, FY2025, at 2025-12-31$464.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure507Total assets, Q1 FY2026, at 2026-03-31$506.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure481Total assets, Q2 FY2026, at 2026-06-30$481.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure496Total assets, Q3 FY2026, at 2026-09-30$496.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure
Current liabilities$m15.6Current liabilities, FY2023, at 2023-12-31$15.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-20, accession 0000950170-25-042623.Report this figure13.2Current liabilities, Q1 FY2024, at 2024-03-31$13.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056846.Report this figure13.8Current liabilities, Q2 FY2024, at 2024-06-30$13.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093858.Report this figure14.3Current liabilities, Q3 FY2024, at 2024-09-30$14.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123245.Report this figure18.6Current liabilities, FY2024, at 2024-12-31$18.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001193125-26-130451.Report this figure16.7Current liabilities, Q1 FY2025, at 2025-03-31$16.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071349.Report this figure58.8Current liabilities, Q2 FY2025, at 2025-06-30$58.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107276.Report this figure18.8Current liabilities, Q3 FY2025, at 2025-09-30$18.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figure25.2Current liabilities, FY2025, at 2025-12-31$25.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure16.1Current liabilities, Q1 FY2026, at 2026-03-31$16.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure24.8Current liabilities, Q2 FY2026, at 2026-06-30$24.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure36.3Current liabilities, Q3 FY2026, at 2026-09-30$36.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure
Total liabilities$m47.4Total liabilities, FY2023, at 2023-12-31$47.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-20, accession 0000950170-25-042623.Report this figure44.0Total liabilities, Q1 FY2024, at 2024-03-31$44.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-056846.Report this figure43.5Total liabilities, Q2 FY2024, at 2024-06-30$43.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093858.Report this figure43.0Total liabilities, Q3 FY2024, at 2024-09-30$43.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123245.Report this figure46.2Total liabilities, FY2024, at 2024-12-31$46.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-30, accession 0001193125-26-130451.Report this figure43.2Total liabilities, Q1 FY2025, at 2025-03-31$43.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0000950170-25-071349.Report this figure1,711Total liabilities, Q2 FY2025, at 2025-06-30$1.71bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0000950170-25-107276.Report this figure2,402Total liabilities, Q3 FY2025, at 2025-09-30$2.40bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figure628Total liabilities, FY2025, at 2025-12-31$628.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure657Total liabilities, Q1 FY2026, at 2026-03-31$657.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure681Total liabilities, Q2 FY2026, at 2026-06-30$681.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure633Total liabilities, Q3 FY2026, at 2026-09-30$633.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure
Shareholders' equity$m151Shareholders' equity, FY2023, at 2023-12-31$150.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001193125-26-130451.Report this figure123Shareholders' equity, Q1 FY2024, at 2024-03-31$123.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figure98.1Shareholders' equity, Q2 FY2024, at 2024-06-30$98.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figure73.0Shareholders' equity, Q3 FY2024, at 2024-09-30$73.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figure96.7Shareholders' equity, FY2024, at 2024-12-31$96.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure66.1Shareholders' equity, Q1 FY2025, at 2025-03-31$66.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure(1,506)Shareholders' equity, Q2 FY2025, at 2025-06-30−$1.51bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure(2,225)Shareholders' equity, Q3 FY2025, at 2025-09-30−$2.23bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure(164)Shareholders' equity, FY2025, at 2025-12-31−$164.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure(150)Shareholders' equity, Q1 FY2026, at 2026-03-31−$150.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure(200)Shareholders' equity, Q2 FY2026, at 2026-06-30−$200.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure(137)Shareholders' equity, Q3 FY2026, at 2026-09-30−$137.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure

Cash flow

Operating cash flow−$32.7m, Q3 FY2026
Capital expenditure$25.0k, Q3 FY2026
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Operating cash flow$m(24.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$24.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-20, accession 0000950170-25-042623. Derived: 12-month figure less the 9-month figure.Report this figure(30.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$30.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0000950170-25-071349.Report this figure(21.8)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$21.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-107276. Derived: 6-month figure less the 3-month figure.Report this figure(23.3)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$23.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-280104. Derived: 9-month figure less the 6-month figure.Report this figure(24.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$24.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001193125-26-130451. Derived: 12-month figure less the 9-month figure.Report this figure(31.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$31.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure(35.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$35.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343607. Derived: 6-month figure less the 3-month figure.Report this figure(53.7)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$53.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-30, accession 0001193125-26-439905. Derived: 9-month figure less the 6-month figure.Report this figure(22.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$22.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001193125-26-130451. Derived: 12-month figure less the 9-month figure.Report this figure(38.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$38.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure(25.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$25.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343607. Derived: 6-month figure less the 3-month figure.Report this figure(32.7)Operating cash flow, Q3 FY2026, three months to 2026-09-30−$32.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-30, accession 0001193125-26-439905. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$111.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-20, accession 0000950170-25-042623. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$114.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0000950170-25-071349.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0000950170-25-107276. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$34.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-280104. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$72.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001193125-26-130451. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$231.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure0.2Capital expenditure, Q2 FY2025, three months to 2025-06-30$152.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343607. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$244.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-30, accession 0001193125-26-439905. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2025, three months to 2025-12-31$314.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001193125-26-130451. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$48.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$120.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343607. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2026, three months to 2026-09-30$25.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-30, accession 0001193125-26-439905. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)59.67m, Q3 FY2026
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Diluted shares (weighted)m shares66.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3166,265,703 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-056846.Report this figure67.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3067,033,150 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093858.Report this figure67.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3067,607,713 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123245.Report this figure68.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3168,030,966 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0000950170-25-071349.Report this figure68.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3068,299,170 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0000950170-25-107276.Report this figure3.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-303,423,499 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-280104.Report this figure6.2Diluted shares (weighted), Q1 FY2025, three months to 2025-03-316,241,207 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure6.3Diluted shares (weighted), Q2 FY2025, three months to 2025-06-306,263,572 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure6.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-306,681,794 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure43.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3143,011,544 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-220689.Report this figure54.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3054,304,456 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-343607.Report this figure59.7Diluted shares (weighted), Q3 FY2026, three months to 2026-09-3059,669,730 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure

Shares outstanding: 61.43mShares outstanding, period not labelled, at 2026-10-2661,434,344 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-10-30, accession 0001193125-26-439905.Report this figure at Oct 26, 2026, from the cover of the 10-Q filed Oct 30, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 03:06 ET. Listed shows no prices and gives no investment advice.